Clinical Trials Logo
  1. Home
  2. Gastritis
  3. NCT02806674

A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection

Gastritis Clinical Trial

Official title:
A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection

Clinical Trial Summary

Approximately 50% of people in the world are infected with H. pylori, and its eradication rate fail to exceed 80% and even fails into an unacceptable range.Various risk factors for infection include lower socioeconomic status, younger age, and geographic location.In the present study, investigators aimed to perform a prevalence survey about risk factors for H. pylori infection.To obtain the higher eradication of H. pylori and find out the relevance between the diverse infection and clinical drug focused on refractory H. pylori infection.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02806674
Study type Interventional
Source The University of Hong Kong-Shenzhen Hospital
Contact Tao Lyu, Doctor
Email lvt@hku-szh.org
Status Recruiting
Phase N/A
Start date July 2016
Completion date December 2019
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04289519 - Endoscopic Findings of Gastritis in Children
Recruiting NCT02353039 - Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis Phase 2
Recruiting NCT05545397 - Sedation Level on Machine Learning With Electroencephalogram in Painless Gastroenteroscopy Patients
Not yet recruiting NCT05510388 - HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients N/A
Completed NCT02724280 - Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy N/A
Not yet recruiting NCT02961296 - Helicobacter Pylori Antibiotic Susceptibility Testing of Korea N/A
Completed NCT02385045 - i-Scan for the Detection of Helicobacter Pylori N/A
Completed NCT00212225 - Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) N/A
Completed NCT04672018 - Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis Phase 2
Not yet recruiting NCT05072938 - Phase IV Clinical Trial to Compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis Phase 4
Completed NCT02597517 - New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy N/A
Completed NCT02296021 - Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy Phase 4
Completed NCT01576289 - Analysis of Biopsies From the Upper Gastrointestinal Tract N/A
Active, not recruiting NCT03509831 - [KJ-INT-002] BE Study Phase 1
Terminated NCT05579444 - Systems Biology of Gastrointestinal and Related Diseases
Suspended NCT04306939 - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Completed NCT05237115 - Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy Phase 4
Completed NCT02393430 - Clinical Effect of Rebamipide on Chronic Gastritis Phase 4
Completed NCT00579410 - Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule N/A
Completed NCT00267475 - Data Bank for Eosinophilic Disorders N/A